FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2016647631> ?p ?o ?g. }

• W2016647631 endingPage "772" @default.
• W2016647631 startingPage "765" @default.
• W2016647631 abstract "Large doses of atrial natriuretic peptide (ANP) inhibit renin and aldosterone secretion in normal man, but the effect of physiological levels is unknown. We, therefore, studied the effect of a low infusion rate of alpha-human ANP (alpha hANP; 0.5 microgram/min for 180 min) on the plasma corticosteroid response to graded physiological doses of angiotensin II (0.5, 1.0, 2.0, and 4.0 ng/kg X min, each for 30 min) and ACTH (6.25, 12.5, 25, and 50 mIU, each for 30 min) in six normal men eating a low salt diet (10 mmol sodium and 100 mmol potassium daily). The angiotensin II and ACTH infusions were given from 0900-1100 h on separate days, during which randomized infusions of placebo or alpha hANP were given from 0800-1100 h according to a single blind protocol. Plasma immunoreactive ANP levels were less than 10 pmol/L on the placebo day compared to 30-50 pmol/L during the alpha hANP infusions, and were not altered by either ACTH or angiotensin II. Compared with the control observations, there was no significant change in arterial pressure or heart rate during either the alpha hANP or angiotensin II infusions. ACTH infusions evoked an incremental response in plasma aldosterone and cortisol, and the dose-response relationship was unaltered by alpha hANP. In contrast, while an incremental and significant increase in plasma aldosterone in response to angiotensin II occurred with the placebo infusion, no significant increase occurred in response to angiotensin during the alpha hANP infusion. The slope of the angiotensin II/aldosterone regression line was significantly less during all alpha hANP infusions compared to that during the placebo infusion (P less than 0.02). In addition, on the ACTH infusion day significant suppression of both PRA (P less than 0.05) and plasma angiotensin II (P less than 0.008) occurred during the alpha hANP infusion compared to that during the placebo infusion, whereas PRA was equally suppressed by angiotensin II in the presence or absence of alpha hANP. alpha hANP also increased urine volume [176 +/- 31 (+/- SEM) vs. 113 +/- 19 mL/mmol creatinine with placebo; P less than 0.03] and sodium excretion (2.14 +/- 0.48 vs. 0.58 +/- 0.22 mmol/mmol creatinine with placebo; P less than 0.004) on the ACTH infusion days. With angiotensin II, urine volume was also significantly increased by alpha hANP (150 +/- 27 vs. 81 +/- 15 mL/mmol creatinine with placebo; P less than 0.03), and urine sodium excretion doubled.(ABSTRACT TRUNCATED AT 400 WORDS)" @default.
• W2016647631 created "2016-06-24" @default.
• W2016647631 creator A5015432494 @default.
• W2016647631 creator A5028935547 @default.
• W2016647631 creator A5041262267 @default.
• W2016647631 creator A5052993141 @default.
• W2016647631 creator A5062684512 @default.
• W2016647631 date "1987-10-01" @default.
• W2016647631 modified "2023-10-15" @default.
• W2016647631 title "Effect of Physiological Levels of Atrial Natriuretic Peptide on Hormone Secretion: Inhibition of Angiotensin-Induced Aldosterone Secretion and Renin Release in Normal Man*" @default.
• W2016647631 cites W1948371562 @default.
• W2016647631 cites W1972620988 @default.
• W2016647631 cites W1974645862 @default.
• W2016647631 cites W1974946514 @default.
• W2016647631 cites W1982550769 @default.
• W2016647631 cites W1984457251 @default.
• W2016647631 cites W1990907166 @default.
• W2016647631 cites W2010329909 @default.
• W2016647631 cites W2021216162 @default.
• W2016647631 cites W2027205055 @default.
• W2016647631 cites W2031639896 @default.
• W2016647631 cites W2035352126 @default.
• W2016647631 cites W2048449846 @default.
• W2016647631 cites W2050512397 @default.
• W2016647631 cites W2059787491 @default.
• W2016647631 cites W2064043930 @default.
• W2016647631 cites W2077534129 @default.
• W2016647631 cites W2080132669 @default.
• W2016647631 cites W2087173844 @default.
• W2016647631 cites W2092220083 @default.
• W2016647631 cites W2093175759 @default.
• W2016647631 cites W2128632518 @default.
• W2016647631 cites W2137639534 @default.
• W2016647631 cites W2411728052 @default.
• W2016647631 cites W2417239947 @default.
• W2016647631 cites W2418017927 @default.
• W2016647631 cites W2428411855 @default.
• W2016647631 doi "https://doi.org/10.1210/jcem-65-4-765" @default.
• W2016647631 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/2821056" @default.
• W2016647631 hasPublicationYear "1987" @default.
• W2016647631 type Work @default.
• W2016647631 sameAs 2016647631 @default.
• W2016647631 citedByCount "104" @default.
• W2016647631 countsByYear W20166476312014 @default.
• W2016647631 countsByYear W20166476312016 @default.
• W2016647631 countsByYear W20166476312017 @default.
• W2016647631 countsByYear W20166476312018 @default.
• W2016647631 countsByYear W20166476312022 @default.
• W2016647631 countsByYear W20166476312023 @default.
• W2016647631 crossrefType "journal-article" @default.
• W2016647631 hasAuthorship W2016647631A5015432494 @default.
• W2016647631 hasAuthorship W2016647631A5028935547 @default.
• W2016647631 hasAuthorship W2016647631A5041262267 @default.
• W2016647631 hasAuthorship W2016647631A5052993141 @default.
• W2016647631 hasAuthorship W2016647631A5062684512 @default.
• W2016647631 hasConcept C126322002 @default.
• W2016647631 hasConcept C134018914 @default.
• W2016647631 hasConcept C138976137 @default.
• W2016647631 hasConcept C185592680 @default.
• W2016647631 hasConcept C198710026 @default.
• W2016647631 hasConcept C2778069365 @default.
• W2016647631 hasConcept C2778525890 @default.
• W2016647631 hasConcept C2908929049 @default.
• W2016647631 hasConcept C56191518 @default.
• W2016647631 hasConcept C71315377 @default.
• W2016647631 hasConcept C71924100 @default.
• W2016647631 hasConcept C84393581 @default.
• W2016647631 hasConceptScore W2016647631C126322002 @default.
• W2016647631 hasConceptScore W2016647631C134018914 @default.
• W2016647631 hasConceptScore W2016647631C138976137 @default.
• W2016647631 hasConceptScore W2016647631C185592680 @default.
• W2016647631 hasConceptScore W2016647631C198710026 @default.
• W2016647631 hasConceptScore W2016647631C2778069365 @default.
• W2016647631 hasConceptScore W2016647631C2778525890 @default.
• W2016647631 hasConceptScore W2016647631C2908929049 @default.
• W2016647631 hasConceptScore W2016647631C56191518 @default.
• W2016647631 hasConceptScore W2016647631C71315377 @default.
• W2016647631 hasConceptScore W2016647631C71924100 @default.
• W2016647631 hasConceptScore W2016647631C84393581 @default.
• W2016647631 hasIssue "4" @default.
• W2016647631 hasLocation W20166476311 @default.
• W2016647631 hasLocation W20166476312 @default.
• W2016647631 hasOpenAccess W2016647631 @default.
• W2016647631 hasPrimaryLocation W20166476311 @default.
• W2016647631 hasRelatedWork W146935509 @default.
• W2016647631 hasRelatedWork W1550989882 @default.
• W2016647631 hasRelatedWork W1968716475 @default.
• W2016647631 hasRelatedWork W1980565209 @default.
• W2016647631 hasRelatedWork W2067602359 @default.
• W2016647631 hasRelatedWork W2076569737 @default.
• W2016647631 hasRelatedWork W2226285639 @default.
• W2016647631 hasRelatedWork W2363957081 @default.
• W2016647631 hasRelatedWork W2406547830 @default.
• W2016647631 hasRelatedWork W2428828763 @default.
• W2016647631 hasVolume "65" @default.
• W2016647631 isParatext "false" @default.
• W2016647631 isRetracted "false" @default.
• W2016647631 magId "2016647631" @default.

• next